U.S. Markets closed
  • S&P 500

    3,841.47
    -11.60 (-0.30%)
     
  • Dow 30

    30,996.98
    -179.03 (-0.57%)
     
  • Nasdaq

    13,543.06
    +12.15 (+0.09%)
     
  • Russell 2000

    2,168.76
    +27.34 (+1.28%)
     
  • Crude Oil

    51.98
    -1.15 (-2.16%)
     
  • Gold

    1,855.50
    -10.40 (-0.56%)
     
  • Silver

    25.57
    -0.29 (-1.12%)
     
  • EUR/USD

    1.2174
    +0.0001 (+0.0122%)
     
  • 10-Yr Bond

    1.0910
    -0.0180 (-1.62%)
     
  • Vix

    21.91
    +0.59 (+2.77%)
     
  • GBP/USD

    1.3685
    -0.0046 (-0.3339%)
     
  • USD/JPY

    103.7500
    +0.2450 (+0.2367%)
     
  • BTC-USD

    32,575.37
    +781.04 (+2.46%)
     
  • CMC Crypto 200

    651.44
    +41.45 (+6.79%)
     
  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     
  • Nikkei 225

    28,631.45
    -125.41 (-0.44%)
     

Invitae Corp (NVTA) COO Kenneth D. Knight Sold $680,901 of Shares

GuruFocus.com
·2 min read

- By insider

COO of Invitae Corp (30-Year Financial, Insider Trades) Kenneth D. Knight (insider trades) sold 13,351 shares of NVTA on 12/16/2020 at an average price of $51 a share. The total sale was $680,901.


Invitae Corp is a genetic information company engaged in genetic diagnostics for hereditary disorders. It provides testing for multiple genes including hereditary cancer, neurological disorders, cardiovascular disorders and other hereditary conditions. Invitae Corp has a market cap of $8.4 billion; its shares were traded at around $47.560000 with and P/S ratio of 21.61. GuruFocus has detected 1 severe warning sign with Invitae Corp. .

CEO Recent Trades:

  • President & CEO Sean E George sold 8,683 shares of NVTA stock on 11/20/2020 at the average price of $47.98. The price of the stock has decreased by 0.88% since.

Directors and Officers Recent Trades:

  • President, Oncology Jason W. Myers sold 253,912 shares of NVTA stock on 12/18/2020 at the average price of $47.49. The price of the stock has increased by 0.15% since.

  • Director Eric Aguiar sold 10,000 shares of NVTA stock on 12/16/2020 at the average price of $51. The price of the stock has decreased by 6.75% since.

  • COO Kenneth D. Knight sold 13,351 shares of NVTA stock on 12/16/2020 at the average price of $51. The price of the stock has decreased by 6.75% since.

  • Chief Commercial Officer Katherine Stueland sold 34,300 shares of NVTA stock on 12/14/2020 at the average price of $58.43. The price of the stock has decreased by 18.6% since.

  • Chief Accounting Officer Robert F. Werner sold 2,427 shares of NVTA stock on 11/24/2020 at the average price of $48.92. The price of the stock has decreased by 2.78% since.

For the complete insider trading history of NVTA, click here

.This article first appeared on GuruFocus.